[go: up one dir, main page]

GB9805557D0 - A combination of therapeutic agents - Google Patents

A combination of therapeutic agents

Info

Publication number
GB9805557D0
GB9805557D0 GBGB9805557.7A GB9805557A GB9805557D0 GB 9805557 D0 GB9805557 D0 GB 9805557D0 GB 9805557 A GB9805557 A GB 9805557A GB 9805557 D0 GB9805557 D0 GB 9805557D0
Authority
GB
United Kingdom
Prior art keywords
combination
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9805557.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Priority to GBGB9805557.7A priority Critical patent/GB9805557D0/en
Publication of GB9805557D0 publication Critical patent/GB9805557D0/en
Priority to US09/622,952 priority patent/US6455552B1/en
Priority to AU28478/99A priority patent/AU2847899A/en
Priority to PCT/GB1999/000801 priority patent/WO1999047171A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9805557.7A 1998-03-16 1998-03-16 A combination of therapeutic agents Ceased GB9805557D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB9805557.7A GB9805557D0 (en) 1998-03-16 1998-03-16 A combination of therapeutic agents
US09/622,952 US6455552B1 (en) 1998-03-16 1999-03-16 Combination of a GABAA α5 inverse agonist and a muscarinic agonist
AU28478/99A AU2847899A (en) 1998-03-16 1999-03-16 Combination of a gaba-a alpha 5 inverse agonist and a muscarinic agonist
PCT/GB1999/000801 WO1999047171A1 (en) 1998-03-16 1999-03-16 Combination of a gaba-a alpha 5 inverse agonist and a muscarinic agonist

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9805557.7A GB9805557D0 (en) 1998-03-16 1998-03-16 A combination of therapeutic agents

Publications (1)

Publication Number Publication Date
GB9805557D0 true GB9805557D0 (en) 1998-05-13

Family

ID=10828628

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9805557.7A Ceased GB9805557D0 (en) 1998-03-16 1998-03-16 A combination of therapeutic agents

Country Status (4)

Country Link
US (1) US6455552B1 (en)
AU (1) AU2847899A (en)
GB (1) GB9805557D0 (en)
WO (1) WO1999047171A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271241B1 (en) 1999-04-02 2001-08-07 Neurogen Corporation Cycloalkyl and aryl fused aminoalkyl-imidazole derivatives: modulators and GLP-1 receptors
US6281237B1 (en) 1999-04-02 2001-08-28 Neurogen Corporation N-phenyl benzimidazolecarboxamide and N-phenyl indolecarboxamide derivatives
US6380210B1 (en) 1999-04-02 2002-04-30 Neurogen Corporation Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors
US6627624B1 (en) 1999-04-02 2003-09-30 Neurogen Corporation Aryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors
US6723332B2 (en) 2000-05-26 2004-04-20 Neurogen Corporation Oxomidazopyridine-carboxamides
US6828329B2 (en) 2000-06-26 2004-12-07 Neurogen Corporation Aryl fused substituted 4-oxy-pyridines
IL159811A0 (en) 2001-07-13 2004-06-20 Neurogen Corp Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands
CA2573673A1 (en) * 2004-07-16 2006-01-26 Proteosys Ag Muscarinic antagonists with parp and sir modulating activity as cytoprotective agents
WO2019180224A1 (en) * 2018-03-22 2019-09-26 Nsc Therapeutics Gmbh Compounds and methods for use in the treatment of microglia-mediated disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647580A (en) 1985-07-18 1987-03-03 Syntex (U.S.A.) Inc. Treatment of Alzheimer's disease
DK198590D0 (en) 1990-08-21 1990-08-21 Novo Nordisk As HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE
GB9503601D0 (en) 1995-02-23 1995-04-12 Merck Sharp & Dohme Method of treatment and method of manufacture of medicament
AU724076B2 (en) 1996-07-25 2000-09-14 Merck Sharp & Dohme Limited Substituted triazolo pyridazine derivatives as inverse agonists of the GABAAalpha5 receptor subtype
AU732455C (en) 1997-05-08 2002-09-05 Merck Sharp & Dohme Limited Substituted 1,2,4-triazolo{3,4-a}phthalazine derivatives as gaba alpha 5 ligands

Also Published As

Publication number Publication date
US6455552B1 (en) 2002-09-24
WO1999047171A1 (en) 1999-09-23
AU2847899A (en) 1999-10-11

Similar Documents

Publication Publication Date Title
GB9805561D0 (en) A combination of therapeutic agents
GB9820113D0 (en) Therapeutic agents
GB9708484D0 (en) Therapeutic agents
GB9816263D0 (en) Therapeutic agents
GB9708945D0 (en) Therapeutic agents
GB9806102D0 (en) Therapeutic agents
GB9704948D0 (en) Therapeutic agents
GB9702524D0 (en) Therapeutic agents
GB9711753D0 (en) Therapeutic agents
GB9713707D0 (en) Therapeutic agents
GB9808663D0 (en) Therapeutic agents
GB9711114D0 (en) Therapeutic agents
GB9801234D0 (en) Therapeutic agents
GB9813576D0 (en) Therapeutic agents
GB9813006D0 (en) Therapeutic agents
GB9801210D0 (en) Therapeutic agents
AP9901436A0 (en) Therapeutic agents
GB9801397D0 (en) Therapeutic agents
GB9805557D0 (en) A combination of therapeutic agents
GB9801202D0 (en) Therapeutic agents
GB9700555D0 (en) Therapeutic agents
GB9810092D0 (en) Therapeutic agents
GB9819484D0 (en) Therapeutic agents
GB9811879D0 (en) Therapeutic agents
GB9805716D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)